Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion in HIV disease

E M Sloand1, J E Groopman

  • 1National Heart, Lung, and Blood Institute, Bethesda, MD 20892-2490, USA.

Current Opinion in Hematology
|November 14, 1997
PubMed
Summary

Cytopenias, including anemia and neutropenia, are common in HIV/AIDS. Current treatments focus on managing these blood count reductions effectively and safely, moving away from routine transfusions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia.

Leukemia·2011
Same author

Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator.

British journal of pharmacology·2010
Same author

Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome.

Leukemia·2009
Same author

Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells.

Oncogene·2009
Same author

Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy.

Leukemia·2008
Same author

Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.

Oncogene·2007

Area of Science:

  • Hematology
  • Infectious Diseases
  • Immunology

Background:

  • Cytopenias (anemia, neutropenia, thrombocytopenia) are common in patients with Human Immunodeficiency Virus (HIV) infection, particularly in Acquired Immunodeficiency Syndrome (AIDS).
  • The exact mechanisms driving these blood count reductions in HIV/AIDS are complex and not fully elucidated.
  • Historically, transfusion was common for anemia in patients on zidovudine, but this practice has declined.

Purpose of the Study:

  • To review the evolving understanding of cytopenias in HIV/AIDS.
  • To discuss the changing clinical practices regarding blood transfusions for HIV-infected patients.
  • To highlight advancements in managing cytopenias.

Main Methods:

  • Review of current medical literature and clinical practices.
  • Discussion of the pathophysiology of cytopenias in HIV/AIDS.
  • Analysis of the impact of new therapies and transfusion considerations.

Main Results:

  • Decreased use of zidovudine and increased use of HIV protease inhibitors have reduced the need for transfusions.
  • Greater awareness of transfusion risks (immune modulation, viral replication) influences clinical decisions.
  • Hematopoietic growth factors offer effective treatment for cytopenias with fewer complications.

Conclusions:

  • Clinical management of cytopenias in HIV/AIDS has shifted towards more conservative transfusion strategies.
  • Further research, including trials on leukodepletion, is needed to understand transfusion-related immune modulation.
  • Hematopoietic growth factors represent a significant advancement in treating cytopenias in this population.

Related Experiment Videos